Adenosine Deaminase (ADA) Peptide
-
- Target See all ADA products
- ADA (Adenosine Deaminase (ADA))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- ANYSLNTDDP LIFKSTLDTD YQMTKRDMGF TEEEFKRLNI NAAKSSFLPE
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ADA antibody,
Alternative Names: ADA control peptide, ADA antibody Blocking Peptide, Anti-ADA Blocking Peptide, Adenosine Deaminase Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- ADA (Adenosine Deaminase (ADA))
- Background
- ADA is an enzyme that catalyzes the hydrolysis of adenosine to inosine. Various mutations have been described for this gene and have been linked to human diseases. Deficiency in this enzyme causes a form of severe combined immunodeficiency disease (SCID), in which there is dysfunction of both B and T lymphocytes with impaired cellular immunity and decreased production of immunoglobulins, whereas elevated levels of this enzyme have been associated with congenital hemolytic anemia.
- Molecular Weight
- 41 kDa
-